Gynecologic Evening Specialty Conference. Karuna Garg, MD University of California San Francisco
|
|
- Olivia Goodman
- 5 years ago
- Views:
Transcription
1 Gynecologic Evening Specialty Conference Karuna Garg, MD University of California San Francisco
2 Disclosure of Relevant Financial Relationships The USCAP requires that anyone in a position to influence or control the content of all CME activities disclose any relevant relationship(s) which they or their spouse/partner have, or have had within the past 12 months with a commercial interest(s) [or the products or services of a commercial interest] that relate to the content of this educational activity and create a conflict of interest. Complete disclosure information is maintained in the USCAP office and has been reviewed by the CME Advisory Committee. Dr. Karuna Garg declares he/she has no conflict(s) of interest to disclose.
3 Case 54 year old female Abdominal pain Cholecystectomy Surgeon noted ascites and ovarian masses
4 Ovary
5 Ovary
6 Ovary
7 Ovary
8 CD117
9 Case Gastrointestinal stromal tumor?
10 DOG 1
11 CD10
12 MIB 1
13 Cyclin D1
14 Endometrial biopsy
15 Case Additional stains: Negative for ER/PR, smooth muscle markers, epithelial markers, FOXL 2, WT1
16 Case Patient underwent hysterectomy
17 Hysterectomy
18
19
20 CD10
21 Cyclin D1
22 Case High grade endometrial stromal sarcoma
23 Outline Changes in classification of endometrial stromal neoplasms Rationale High grade endometrial stromal sarcoma Diagnosis and differential diagnosis
24 Evolution in classification of endometrial stromal tumors Endometrial stromal tumors Endometrial stromal nodule Low grade ESS High grade ESS
25 Evolution in classification of endometrial stromal tumors Endometrial stromal tumors Endometrial stromal nodule Low grade ESS 2003 WHO classification High grade ESS Endometrial stromal nodule Low grade ESS Undifferentiated endometrial sarcoma
26 Evolution in classification of endometrial stromal tumors Endometrial stromal tumors Endometrial stromal nodule Low grade ESS High grade ESS 2003 WHO classification Endometrial stromal nodule Low grade ESS 2014 WHO classification Undifferentiated endometrial sarcoma Endometrial stromal nodule Low grade ESS High grade ESS Undifferentiated uterine sarcoma
27 Endometrial stromal tumors: 2014 WHO classification 1. Endometrial stromal nodule 2. Low grade endometrial stromal sarcoma 3. High grade endometrial stromal sarcoma 4. Undifferentiated uterine sarcoma
28 Evolution in classification of endometrial stromal tumors: Rationale Stromal neoplasms ( composed of cells identical to or closely resembling endometrial stroma ) Endometrial stromal nodule Low grade ESS <10 mitoses per 10 hpf High grade ESS 10 mitoses per 10 hpf 10 year survival 100% 5 year survival 55% Other features evaluated but not found to be prognostic: Cellular atypia: More in high grade but overlap Necrosis Norris and Taylor, Cancer 1966
29 Evolution in classification of endometrial stromal tumors: Rationale Problems with high grade ESS: Definition of high grade ESS not followed (no resemblance with endometrial stroma) Range of tumors including leiomyosarcoma, MMMT, undifferentiated sarcoma Mitotic count alone not significant
30 Evolution in classification of endometrial stromal tumors: Rationale Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma are distinct Mitotic activity in a typical ESS has no prognostic significance Evans, HL. Cancer 1982
31 Evolution in classification of endometrial stromal tumors: Rationale 117 cases Included cases composed exclusively of uniform cells with scant cytoplasm that resembled the cells of proliferative phase endometrial stroma (although cells could have grade 1 3 atypia) Stage most important prognostic factor On univariate analysis: Mitotic index and cytologic atypia not predictive of clinical outcome in stage 1 patients Chang KL, et al. Am J Surg Pathol 1990
32 Evolution in classification of endometrial stromal tumors: Rationale FIG. 2. Endometrial sarcoma with cellular atypism. The cytologic features illustrated here represent the most severe degree of atypia (Grade 3) we accept within the endometrial stromal sarcoma category. The nuclei are slightly enlarged, and the nuclear membranes are somewhat irregular; but the cells are mostly uniform, and the chromatin is still delicate. Sarcomas composed of cells with greater pleomorphism and nuclear anaplasia are placed in the undifferentiated sarcoma group. Chang KL, et al. Am J Surg Pathol 1990
33 Stage I Stage III/IV Increasing cytologic atypia associated with increase in relapse rate High grade ESS Chang KL, et al. Am J Surg Pathol 1990
34 Evolution in classification of endometrial stromal tumors Endometrial stromal tumors Endometrial stromal nodule Low grade ESS High grade ESS Endometrial stromal nodule 2003 WHO classification Low grade ESS Undifferentiated endometrial sarcoma
35 Evolution in classification of endometrial stromal tumors: Rationale 2003 WHO classification: 1. Endometrial stromal nodule 2. Low grade endometrial stromal sarcoma 3. Undifferentiated endometrial sarcoma
36 Evolution in classification of endometrial stromal tumors: Rationale Problems with 2003 WHO classification: Undifferentiated endometrial sarcoma heterogeneous category Tumors with intermediate features or high grade ESS like features (grade 2 3 atypia) Tumors with components of high grade and low grade ESS
37 Evolution in classification of endometrial stromal tumors: Rationale 1. Low grade ESS 2. Undifferentiated endometrial sarcoma with uniform nuclei (UES U) 3. Undifferentiated endometrial sarcoma with pleomorphic nuclei (UES P) LG ESS UES U UES P Aberrant p % ER + /+ JAZF1 fusion 6/12 (50%) 1/3 (33%) 0/3 (0%) Dead of disease 0/13 (0%) 4/7 (57%) 3/5 (60%) Kurihara S, et al. Am J Surg Pathol 2008
38 Evolution in classification of endometrial stromal tumors: Rationale
39 The Clinicopathologic Features of YWHAE FAM22 Endometrial Stromal Sarcomas: A Histologically Highgrade and Clinically Aggressive Tumor. Lee, Cheng Han; MD, PhD; Marino Enriquez, Adrian; Ou, Wenbin; Zhu, Meijun; Ali, Rola; Chiang, Sarah; Amant, Frederic; Gilks, C; van de Rijn, Matt; MD, PhD; Oliva, Esther; Debiec Rychter, Maria; Dal Cin, Paola; Fletcher, Jonathan; Nucci, Marisa American Journal of Surgical Pathology. 36(5): , May DOI: /PAS.0b013e31824a7b1a FIGURE 7. Proposed classification for pure uterine sarcomas Lippincott Williams & Wilkins, Inc. Published by Lippincott Williams & Wilkins, Inc. 2
40 Increasing cytologic atypia associated with increase in relapse rate High grade ESS Stage III/IV Chang KL, et al. Am J Surg Pathol 1990
41 Evolution in classification of endometrial stromal tumors Endometrial stromal tumors Endometrial stromal nodule Low grade ESS High grade ESS Endometrial stromal nodule 2003 WHO classification Low grade ESS Undifferentiated endometrial sarcoma 2014 WHO classification Endometrial stromal nodule Low grade ESS High grade ESS Undifferentiated uterine sarcoma
42 Evolution in classification of endometrial stromal tumors: Rationale 2014 WHO classification: 1. Endometrial stromal nodule 2. Low grade endometrial stromal sarcoma 3. High grade endometrial stromal sarcoma 4. Undifferentiated uterine sarcoma
43 High grade endometrial stromal sarcoma WHO definition: A malignant tumor of endometrial stromal derivation with high grade, round cell morphology sometimes associated with a low grade spindle cell component that is mostly fibromyxoid. (ESS with YWHAE rearrangement) Rarely a high grade sarcoma is seen with areas that have the appearance of a conventional low grade ESS and can also be diagnosed as high grade ESS. (but also included in undifferentiated uterine sarcoma)
44 YWHAE FAM22 rearranged ESS YWHAE NUTM2 t(10;17)(q22;p13) years (mean 50 yrs) Abnormal vaginal bleeding Pelvic mass Extra uterine disease at presentation Lee CH, et al. Am J Surg Pathol 2012
45 YWHAE FAM22 rearranged ESS Gross features: Exophytic polypoid or intramural mass Tan yellow cut surface Hemorrhage and necrosis Often deep myometrial invasion Extra uterine disease
46 YWHAE FAM22 rearranged ESS Tongue like myometrial invasion Rich capillary network Vascular invasion No pleomorphism Unlike low grade ESS: Higher grade nuclei, mitoses and necrosis
47 YWHAE FAM22 rearranged ESS Round cell component: Cellular Nested with a rich capillary network Round epithelioid cells with scant to moderate clear to pink cytoplasm Large nuclei with irregular contours and inconspicuous nucleoli Brisk mitoses Necrosis Can have pseudoglandular, pseudopapillary or sex cord like areas Spindle cell component: Resembles fibromyxoid low grade ESS Low cellularity Bland spindle cells in a fibromyxoid matrix Low mitotic activity No necrosis May be composed of one or both components (abruptly juxtaposed)
48 Round cell component Spindle cell component
49 Spindle cell component Round cell component
50 Spindle cell component Round cell component
51 Lee CH, et al. Am J Surg Pathol 2012
52 YWHAE FAM22 rearranged ESS Round cell component: CD10 negative ER/PR negative/focal Cyclin D1: Positive C kit: Positive MIB 1: 20 30% Spindle cell component: CD10 positive ER/PR positive Cyclin D1: weak/patchy C kit: weak/patchy MIB 1: Low
53 CD10 in spindle cell component CD10 in round cell component
54 Cyclin D1 in spindle cell component Cyclin D1 in round cell component Strong nuclear staining in >70% of tumor cells
55 YWHAE FAM22 rearranged ESS: Cyclin D1 Sensitive Not specific for the presence of YWHAE rearrangement YWHAE ESS = Cyclin D1 +/ CD10 Cyclin D1 as a Diagnostic Immunomarker for Endometrial Stromal Sarcoma With YWHAE FAM22 Rearrangement. Lee, Cheng Han; MD, PhD; Ali, Rola; Rouzbahman, Marjan; Marino Enriquez, Adrian; Zhu, Meijun; Guo, Xiangqian; Brunner, Alayne; Chiang, Sarah; Leung, Samuel; Nelnyk, Nataliya; Huntsman, David; Blake Gilks, C; Nielsen, Torsten; MD, PhD; Cin, Paola; van de Rijn, Matt; MD, PhD; Oliva, Esther; Fletcher, Jonathan; Nucci, Marisa American Journal of Surgical Pathology. 36(10): , October DOI: /PAS.0b013e31825fa Lippincott Williams & Wilkins, Inc. Published by Lippincott Williams & Wilkins, Inc. 2
56 CD117: Cytoplasmic and membranous staining in round cell component
57 YWHAE FAM22 rearranged ESS: c kit Moderate to strong cytoplasmic and membranous staining for c kit in round cell component Fibromyxoid/spindle component negative or patchy cytoplasmic staining No c kit mutations detected DOG 1 negative Lee CH, et al. Mod Pathol 2014
58 YWHAE FAM22 rearranged ESS Molecular analysis: FISH RT PCR Specific rearrangement Not seen in multiple adult tumors including smooth muscle tumors, adenosarcoma, carcinosarcoma and undifferentiated uterine sarcoma Also seen in clear cell sarcoma of the kidney YWHAE and JAZF1 rearrangements mutually exclusive
59 YWHAE FAM22 rearranged ESS Clinical outcome Patients frequently present at high stages Clinically aggressive 2/10 dead of disease (2 years) 7/10 alive with disease (1 10 years) 1/10 No evidence of disease (3.75 years) Lee CH, et al. Am J Surg Pathol 2012
60 YWHAE FAM22 rearranged ESS Therapeutic implications: Limited data suggests that adjuvant chemotherapy and radiation may provide survival benefit No response to hormonal therapy
61 Differential diagnosis 1. Low grade endometrial stromal sarcoma 2. Undifferentiated endometrial sarcoma 3. Smooth muscle tumors 4. Gastrointestinal stromal tumor (GIST) 5. Ewing sarcoma
62 Low grade versus high grade ESS Morphology: Low grade ESS High grade ESS Nuclei Small, smooth contours Large, irregular contours Mitotic activity Usually <5 mitoses per 10 hpf High Tumor necrosis Absent Frequently present Immunophenotype: CD10, ER, PR Positive Negative/focal Mib 1 Low High CD117 Focal/patchy Can be positive Cyclin D1 Focal/patchy Can be positive Molecular genetics: JAZF1/SUZ12/PHF1/EPC1 rearrangements YWHAE FAM22 rearrangement
63 Low grade versus high grade ESS Prognostic and therapeutic implications Can be problematic
64 Low grade ESS
65 Low grade versus high grade ESS?
66 Low grade versus high grade ESS?
67 ER Mib 1 CD10 Cyclin D1
68 Undifferentiated uterine sarcoma No resemblance to endometrial stroma Lacks specific differentiation Nuclear pleomorphism and anaplasia Immunophenotypic overlap Tp53 mutations (Aberrant p53 staining may favor undifferentiated sarcoma) Complex chromosomal changes Very poor prognosis
69
70 Undifferentiated carcinoma Morphologic overlap Presence of hyperplasia or low grade endometrioid adenocarcinoma Presence of lymph node metastasis? Immunohistochemistry of limited use Focal but strong staining for epithelial markers Cyclin D1 probably not helpful MMR proteins
71
72
73
74 EMA
75 Gastrointestinal stromal tumor (GIST) Problematic differential in extra uterine sites such as ovary Morphologic overlap Immunophenotypic overlap
76 Gastrointestinal stromal tumor (GIST)
77 Gastrointestinal stromal tumor (GIST)
78 DOG 1
79 High grade ESS versus GIST CD117 Cyclin D1 DOG 1 High grade +/ +/ ESS GIST + +/ + Panel should include c kit, cyclin D1 and DOG 1
80 Back to our case.. High grade ESS
81 Case Tumor sent to Mayo Clinic for FISH No rearrangement of the JAZF1, PHF1 or YWHAE genes identified Diagnosis? High grade ESS (permeative myometrial invasion, resemblance to endometrial stroma and nuclear uniformity) What other tumor types belong to high grade ESS?
82 1. YWHAE rearranged ESS 2. De differentiated ESS 3. Other uniform high grade sarcomas that lack YWHAE rearrangements
83 High grade ESS De differentiated ESS: Low grade ESS and high grade sarcoma Heterologous differentiation Cyclin D1 negative At presentation or in recurrence
84 De differentiated ESS Classification? WHO 2014: Included in both high grade ESS and undifferentiated uterine sarcoma Clinical outcome? More aggressive?
85 High grade ESS Other uniform high grade sarcomas that lack YWHAE rearrangements? Further studies Better delineation
86 High grade ESS Round cells and/or spindle cells Low grade ESS and high grade sarcoma Uniform cells nonspecific morphology ER/PR /focal+ CD10 Cyclin D1 + ER/PR /focal+ CD10 Cyclin D1 ER/PR /focal+ CD10 /+ Cyclin D1 /+ YWHAE rearranged ESS De differentiated ESS High grade ESS, NOS
87 Conclusions High grade ESS re introduced in 2014 WHO classification of endometrial stromal tumors Some (but not all) have YWHAE rearrangements Further work: Refinement of tumor types belonging to category of highgrade ESS (expansion of WHO definition?) Clinical and therapeutic implications of a diagnosis of high grade ESS? Do different subtypes have significant clinical differences? Low grade ESS with increased mitoses and/or tumor necrosis?
88 Thank you
89 References 1. Norris HJ, Taylor HB. Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer. Jun 1966;19(6): Chang KL, Crabtree GS, Lim Tan SK, Kempson RL, Hendrickson MR. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. The American journal of surgical pathology. May 1990;14(5): Kurihara S, Oda Y, Ohishi Y, et al. Endometrial stromal sarcomas and related high grade sarcomas: immunohistochemical and molecular genetic study of 31 cases. The American journal of surgical pathology. Aug 2008;32(8): Lee CH, Ou WB, Marino Enriquez A, et al fusion oncogenes in high grade endometrial stromal sarcoma. Proceedings of the National Academy of Sciences of the United States of America. Jan ;109(3): Sciallis AP, Bedroske PP, Schoolmeester JK, et al. High grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features. The American journal of surgical pathology. Sep 2014;38(9): Lee CH, Marino Enriquez A, Ou W, et al. The clinicopathologic features of YWHAE FAM22 endometrial stromal sarcomas: a histologically high grade and clinically aggressive tumor. The American journal of surgical pathology. May 2012;36(5): Lee CH, Ali RH, Rouzbahman M, et al. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE FAM22 rearrangement. The American journal of surgical pathology. Oct 2012;36(10):
90 Important Information Regarding CME/SAMs The Online CME/Evaluations/SAM claim process will only be available on the USCAP website until October 2, No claims can be processed after that date! After October 2, 2015 you will NOT be able to obtain any CME or SAMs credits for attending this meeting.
91 Thank You! Please go to the USCAP website to complete your Evaluation of the course and claim CME and/or SAMs Credits.
CyclinD1 Positive High-Grade Endometrial Stromal Sarcoma: A Fascinating Entity!
Case Report DOI: 10.21276/APALM.1530 CyclinD1 Positive High-Grade Endometrial Stromal Sarcoma: A Fascinating Entity! Divya Shelly*, Imtiaz Ahmed, Sampath K. Srinivasagowda and Reena Bharadwaj Department
More informationESS: Pathologic Insights
GEIS XVI INTERNATIONAL SYMPOSIUM Seville 4th October 2018 ESS: Pathologic Insights Sílvia Bagué The Royal Marsden Hospital London (United Kingdom) I have no conflicts of interest Endometrial stromal sarcoma
More informationWhat really matters When and Why. Pathology of Uterine Mesenchymal Lesions. Nafisa Wilkinson London
What really matters When and Why Pathology of Uterine Mesenchymal Lesions Nafisa Wilkinson London Patient centred approach immunohistochemistry Histological diagnosis Next generation sequencing Genetic
More informationEndometrial Stromal Tumors
Endometrial Stromal Tumors WHO Categories: Endometrial Stromal Nodule (ESN) Endometrial Stromal Sarcoma, low grade (LGESS) Endometrial Stromal Sarcoma, high grade (HGESS) Undifferentiated Uterine Sarcoma
More informationMody. AIS vs. Invasive Adenocarcinoma of the Cervix
Common Problems in Gynecologic Pathology Michael T. Deavers, M.D. Houston Methodist Hospital, Houston, Texas Common Problems in Gynecologic Pathology Adenocarcinoma in-situ (AIS) of the Cervix vs. Invasive
More informationACCME/Disclosures ALK FUSION-POSITIVE MESENCHYMAL TUMORS. Tumor types with ALK rearrangements. Anaplastic Lymphoma Kinase. Jason L.
Companion Meeting of the International Society of Bone and Soft Tissue Pathology The Evolving Concept of Mesenchymal Tumors ALK FUSION-POSITIVE MESENCHYMAL TUMORS Jason L. Hornick, MD, PhD March 13, 2016
More information64 YO lady THBSO for prolapse At gross : A 3 cm endometrial polyp in the fundus
Case 6 64 YO lady THBSO for prolapse At gross : A 3 cm endometrial polyp in the fundus Numerous irregular, large glands with leaf-like pattern Large glands with broad-based papillary infolding into the
More information3/24/2017. Disclosure of Relevant Financial Relationships. Mixed Epithelial Endometrial Carcinoma. ISGyP Endometrial Cancer Project
Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content of CME disclose any relevant financial relationship
More informationDisclosure. Case. Mixed Tumors of the Uterine Corpus and Cervix. I have nothing to disclose
Mixed Tumors of the Uterine Corpus and Cervix Marisa R. Nucci, M.D. Division of Women s and Perinatal Pathology Department of Pathology Brigham and Women s Hospital Boston, MA UCSF Current Issues in Anatomic
More information3/27/2017. Pulmonary Pathology Specialty Conference. Disclosure of Relevant Financial Relationships. Clinical History:
Pulmonary Pathology Specialty Conference Saul Suster, M.D. Medical College of Wisconsin Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position
More informationInternational Society of Gynecological Pathologists Symposium 2007
International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade
More informationA 25 year old female with a palpable mass in the right lower quadrant of her abdomen
May 2016 A 25 year old female with a palpable mass in the right lower quadrant of her abdomen Contributed by: Paul Ndekwe, MD, Resident Physician, Indiana University School of Department of Pathology and
More informationDepartment of Pathology, Royal Group of Hospitals Trust, Belfast, Northern Ireland.
UTERINE ADENOSARCOMA W Glenn McCluggage Department of Pathology, Royal Group of Hospitals Trust, Belfast, Northern Ireland. Definition of Adenosarcoma: A mixed tumor composed of benign neoplastic glandular
More informationOriginal Article Endometrial stromal sarcoma: a clinicopathological analysis of 14 cases
Int J Clin Exp Pathol 2018;11(5):2799-2804 www.ijcep.com /ISSN:1936-2625/IJCEP0073760 Original Article Endometrial stromal sarcoma: a clinicopathological analysis of 14 cases Fuqiang Wang *, Ruixue Lei
More informationFemale Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan
Female Genital Tract Lab Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan Ovarian Pathology A 20-year-old female presented with vague left pelvic pain. Pelvic exam revealed
More informationWhen Immunostains Can Get You in Trouble: Gynecologic Pathology p16: Panacea or Pandora s Box?
When Immunostains Can Get You in Trouble: Gynecologic Pathology p16: Panacea or Pandora s Box? Teri A. Longacre, MD Stanford Medicine Stanford California pi6 in Gynecologic Pathology: Panacea or Pandora
More informationGOBLET CELL CARCINOID. Hanlin L. Wang, MD, PhD University of California Los Angeles
GOBLET CELL CARCINOID Hanlin L. Wang, MD, PhD University of California Los Angeles Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to
More informationGOBLET CELL CARCINOID
GOBLET CELL CARCINOID Hanlin L. Wang, MD, PhD University of California Los Angeles Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to
More information05/07/2018. Types of challenges. Challenging cases in uterine pathology. Case 1 ` 65 year old female Post menopausal bleeding Uterine Polyp
Types of challenges Challenging cases in uterine pathology Nafisa Wilkinson Gynaecological Pathologist UCLH London Lack of complete history often, NO clinical history at all! Cases from other centres often
More informationBartholin Gland Carcinomas
Bartholin Gland Carcinomas Hugo Horlings MD PhD The Netherlands Cancer Institute Amsterdam, The Netherlands Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee)
More informationCurrent Concept in Ovarian Carcinoma: Pathology Perspectives
Current Concept in Ovarian Carcinoma: Pathology Perspectives Rouba Ali-Fehmi, MD Professor of Pathology The Karmanos Cancer Institute, Wayne State University School of Medicine Current Concept in Ovarian
More informationDiagnostically Challenging Cases in Gynecologic Pathology
Diagnostically Challenging Cases in Gynecologic Pathology Eric C. Huang, M.D., Ph.D. Department of Pathology and Laboratory Medicine University of California, Davis Medical Center Case 1 Presentation 38
More informationCME/SAM. Diagnosis of Endometrial Stromal Tumors. A Clinicopathologic Study of 25 Biopsy Specimens With Identification of Problematic Areas
AJCP / Original Article Diagnosis of Endometrial Stromal Tumors A Clinicopathologic Study of 25 Biopsy Specimens With Identification of Problematic Areas Sten Stemme, MD, PhD, 1 Mehran Ghaderi, PhD, 1
More informationUniversity Journal of Pre and Para Clinical Sciences
ISSN 2455 2879 Volume 2 Issue 1 2016 Metaplastic carcinoma breast a rare case report Abstract : Metaplastic carcinoma of the breast is a rare malignancy with two distinct cell lines described as a breast
More informationACCME/Disclosures. Cribriform Lesions of the Prostate. Case
Cribriform Lesions of the Prostate Ming Zhou, MD, PhD Departments of Pathology and Urology New York University Langone Medical Center New York, NY Ming.Zhou@NYUMC.ORG ACCME/Disclosures The USCAP requires
More information3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates
J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates Signs
More informationEndometrial Metaplasia, Hyperplasia & Other Cancer Mimics: a Consultant s Experience
Endometrial Metaplasia, Hyperplasia & Other Cancer Mimics: a Consultant s Experience Pacific Northwest Society of Pathologists Vancouver, B.C. September 26, 2015 Teri A. Longacre, M.D. longacre@stanford.edu
More informationCASO 1. Xavier Matias-Guiu Hospital Universitari Arnau de Vilanova, Universitat de Lleida, IRBLLEIDA.
CASO 1 Xavier Matias-Guiu Hospital Universitari Arnau de Vilanova, Universitat de Lleida, IRBLLEIDA. ASSESSMENT OF PRIMARY ORIGIN IN PATIENTS WITH A PREVIOUS HISTORY OF CANCER Primary Tumor T1 T5 T6 T13
More informationClinicopathologic correlation of endometrial stromal sarcomas: a retrospective study of 42 cases
Original Article Clinicopathologic correlation of endometrial stromal sarcomas: a retrospective study of 42 cases Fengjie Wang 1,2, Yongfen Yi 1, Yi Luo 3, Jing Chen 1 1 Department of Pathology, Molecular
More informationGynecologic Malignancies. Kristen D Starbuck 4/20/18
Gynecologic Malignancies Kristen D Starbuck 4/20/18 Outline Female Cancer Statistics Uterine Cancer Adnexal Cancer Cervical Cancer Vulvar Cancer Uterine Cancer Endometrial Cancer Uterine Sarcoma Endometrial
More informationUTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE
UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE Case: Adenosarcoma with heterologous elements and stromal overgrowth o TAH, BSO, omentectomy, staging biopsies of cul-de-sac, bladder
More informationPathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON
Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON Presentation outline Background and epidemiology of sarcomas Sarcoma classification Sarcoma
More informationNormal endometrium: A, proliferative. B, secretory.
Normal endometrium: A, proliferative. B, secretory. Nội mạc tử cung Nội mạc tử cung Cyclic changes in endometrium.. Approximate relationship of useful microscopic changes. Arias-Stella reaction in endometrial
More informationInteresting Cases in Gynecologic Pathology. Michael Ward, MD Surgical Pathology Fellow University of Utah Health Sciences Center Salt Lake City, UT
Interesting Cases in Gynecologic Pathology Michael Ward, MD Surgical Pathology Fellow University of Utah Health Sciences Center Salt Lake City, UT Case 1 History: 50 year old woman with a uterine mass
More informationACCME/Disclosures. Risk of Gyne Ca in HBOC. Molecular basis of HBOC. Hereditary Ovarian and Breast Cancer Syndrome
Hereditary Ovarian and Breast Cancer Syndrome C. Blake Gilks, MD Dept of Pathology Vancouver General Hospital University of British Columbia Blake.gilks@vch.ca The USCAP requires that anyone in a position
More informationStandards and datasets for reporting cancers Dataset for histopathological reporting of uterine sarcomas. September 2018
Standards and datasets for reporting cancers Dataset for histopathological reporting of uterine sarcomas September 2018 Authors: Professor W Glenn McCluggage, Royal Group of Hospitals, Belfast Professor
More informationProblem 1: Differential of Neuroendocrine Carcinoma 3/23/2017. Disclosure of Relevant Financial Relationships
Differential of Neuroendocrine Carcinoma Alain C. Borczuk,MD Weill Cornell Medicine Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control
More informationDisclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1
Disclosure Relevant Financial Relationship(s) None Off Label Usage None 2013 MFMER slide-1 Case Presentation A 43 year old male, with partial nephrectomy for a right kidney mass 2013 MFMER slide-2 2013
More informationUterine Mesenchymal Tumors from a Gynaecological Point of View: A Mini-Review
EC Gynaecology Special Issue - 2017 Uterine Mesenchymal Tumors from a Gynaecological Point of View: A Mini-Review Mini Review Dr. Huseyin Aydogmus, Dr. Servet Gencdal, Dr. Nihan Gencdal and Dr. Serpil
More informationCase: The patient is a 24 year- old female who was found to have multiple mural nodules within the antrum. Solid and cystic components were noted on
Case: The patient is a 24 year- old female who was found to have multiple mural nodules within the antrum. Solid and cystic components were noted on imaging. There is no significant past medical history.
More informationARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.
1 ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY Jonathan I. Epstein Professor Pathology, Urology, Oncology The Reinhard Professor of Urological
More informationInternational Journal of Case Reports in Medicine
International Journal of Case Reports in Medicine Vol. 2013 (2013), Article ID 665097, 28 minipages. DOI:10.5171/2013.665097 www.ibimapublishing.com Copyright 2013 Hemalatha A. L., Varna I, Deepthi B.
More informationEvening Specialty Conference Bone and Soft Tissue Pathology. Diagnostic pitfalls in bone and soft tissue pathology
Evening Specialty Conference Bone and Soft Tissue Pathology. Case 1 Elizabeth G Demicco, MD, PhD Mount Sinai Hospital, New York Disclosure of Relevant Financial Relationships USCAP requires that all planners
More informationEvaluating and Reporting Gastrointestinal Stromal Tumors after Imatinib Mesylate Treatment
The Open Pathology Journal, 2009, 3, 53-57 53 Open Access Evaluating and Reporting Gastrointestinal Stromal Tumors after Imatinib Mesylate Treatment Katie L. Dennis * and Ivan Damjanov Department of Pathology
More informationAtypical Hyperplasia/EIN
EIN Atypical Hyperplasia/EIN Based on scientific and diagnostic advances, in 2014 the WHO moved that the precursor lesion for endometrioid carcinoma be atypical hyperplasia/ein, rather than what was previously
More information5 Mousa Al-Abbadi. Ola Al-juneidi & Obada Zalat. Ahmad Al-Tarefe
5 Mousa Al-Abbadi Ola Al-juneidi & Obada Zalat Ahmad Al-Tarefe Abnormal Uterine Bleeding (AUB) AUB is a very common scenario or symptom where women complain of menorrhagia (heavy and/or for long periods),
More information57th Annual HSCP Spring Symposium 4/16/2016
An Unusual Malignant Spindle Cell Lesion to Involve the Breast Erinn Downs-Kelly, D.O. Associate Professor of Pathology University of Utah & ARUP Laboratories No disclosures Case 39 y/o female with no
More informationDepartment of Obstetrics and Gynecology, Landesklinikum Thermenregion Mödling, Sr. M. Restitutagasse 12,
SAGE-Hindawi Access to Research Pathology Research International Volume 2010, Article ID 608519, 5 pages doi:10.4061/2010/608519 Case Report Undifferentiated Endometrial Sarcoma of the Ovary: A Case Report
More informationDiplomate of the American Board of Pathology in Anatomic and Clinical Pathology
A 33-year-old male with a left lower leg mass. Contributed by Shaoxiong Chen, MD, PhD Assistant Professor Indiana University School of Medicine/ IU Health Partners Department of Pathology and Laboratory
More informationEndometrial Stromal Sarcoma Arising from Endometrial Polyp: A Case Report
Kobe J. Med. Sci., Vol. 64, No. 2, pp. E36-E42, 2018 Endometrial Stromal Sarcoma Arising from Endometrial Polyp: A Case Report SAKI SATO 1, YOJIRO OJIMA 1, MASATOSHI KANDA 1, TOMOHIKO KIZAKI 2 and NORIYUKI
More informationFinancial disclosures
Mesenchymal Neoplasms with Melanocytic Differentiation By Konstantinos Linos MD, FCAP, FASDP Bone, Soft Tissue and Dermatopathology Assistant Professor of Pathology Dartmouth-Hitchcock Medical Center Geisel
More information3/24/2017 DENDRITIC CELL NEOPLASMS: HISTOLOGY, IMMUNOHISTOCHEMISTRY, AND MOLECULAR GENETICS. Disclosure of Relevant Financial Relationships
DENDRITIC CELL NEOPLASMS: HISTOLOGY, IMMUNOHISTOCHEMISTRY, AND MOLECULAR GENETICS Jason L. Hornick, M.D., Ph.D. Director of Surgical Pathology and Immunohistochemistry Brigham and Women s Hospital Professor
More informationEndometrial Stromal Sarcoma of the Uterus with Arterial Tumor Embolus
ISPUB.COM The Internet Journal of Gynecology and Obstetrics Volume 12 Number 1 Endometrial Stromal Sarcoma of the Uterus with Arterial Tumor Embolus D Feng, D Wolfson Citation D Feng, D Wolfson. Endometrial
More informationUTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS
Review Journal of Translational Medicine and Research, volume 19, no. 1-2, 2014 UTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS N. Bacalbaæa 1, A. Traistaru 2, I. Bãlescu 3 1 Carol Davila University of Medicine
More informationCase 2. Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset
Case 2 Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset History 24 year old male presented with a 3 day history of right flank pain, sharp in nature Denies fever, chills, hematuria or
More informationDiagnostic problems in uterine smooth muscle tumors
Diagnostic problems in uterine smooth muscle tumors Marina Kos Ljudevit Jurak Clinical Department of Pathology, Clinical Hospital Center Sestre milosrdnice, Zagreb Institute of Pathology, University of
More informationChapter 2: Initial treatment for endometrial cancer (including histologic variant type)
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?
More informationPresenter: Yeh-Han Wang M.D.
Korea-Taiwan-Japan Joint Meeting for Gynecological Pathology Mini-lecture Female Adnexal Tumor of Probable Wolffian Origin (FATWO) in Taiwan: A Small Case Series and Literature Review Presenter: Yeh-Han
More informationNew Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%
Uterine Malignancy New Cancer Cases By Site 2010 Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3% Cancer Deaths By Site 2010 Lung 26% Breast 15% Colo-Rectal 9% Pancreas 7%
More informationEndometrial Stromal Sarcoma
May 26, 2011 By Sushila Ladumor, MD [1] Endometrial stromal sarcoma (ESS) is a rare malignant tumor of the endometrium, occurring in the age group of 40-50 years. History The 50-year-old, female patient
More informationNo financial or other disclosures
Case 2014-5 Esther N. Bit-Ivan, DO Northwestern University Jason Wang, MD Jason Park, MD Korgun Koral, MD Children s Medical Center Charles Timmons, MD Veena Rajaram, MD No financial or other disclosures
More information3/28/2017. Disclosure of Relevant Financial Relationships. GU Evening Subspecialty Case Conference. Differential Diagnosis:
GU Evening Subspecialty Case Conference Rajal B. Shah, M.D. VP, Medical Director, Urologic Pathology Miraca Life Sciences, Irving, Texas Clinical Associate Professor of Pathology Baylor College of Medicine,
More informationCase year old female presented with asymmetric enlargement of the left lobe of the thyroid
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More informationCase 4 Diagnosis 2/21/2011 TGB
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More informationIntravascular Endometrium Mimicking Vascular Invasion
ISPUB.COM The Internet Journal of Pathology Volume 12 Number 1 A Papanicolau, G Lin Citation A Papanicolau, G Lin.. The Internet Journal of Pathology. 2010 Volume 12 Number 1. Abstract Intravascular endometrium
More informationNeoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath
Neoplasia 2018 Lecture 2 Dr Heyam Awad MD, FRCPath ILOS 1. List the differences between benign and malignant tumors. 2. Recognize the histological features of malignancy. 3. Define dysplasia and understand
More informationScotland and Northern Ireland EQA Scheme. Circulation 46
Scotland and Northern Ireland EQA Scheme Circulation 46 Special Educational Cases E1 and E2 Presented by Dr K Robertson Case E1 Female 42 year old with heavy menstrual and intermenstrual bleeding. IUS
More informationof 20 to 80 and subsequently declines [2].
- - According to the 2014 World Health Organization (WHO) classification and tumor morphology, primary ovarian tumors are subdivided into three categories: epithelial (60%), germ cell (30%), and sex-cord
More informationHepatic Lymphoma Diagnosis An Algorithmic Approach
Hepatic Lymphoma Diagnosis An Algorithmic Approach Ryan M. Gill, M.D., Ph.D. University of California, San Francisco PLEASE TURN OFF YOUR CELL PHONES Disclosure of Relevant Financial Relationships USCAP
More information6/5/2010. Outline of Talk. Endometrial Alterations That Mimic Cancer & Vice Versa: Metaplastic / reactive changes. Problems in Biopsies/Curettages
Outline of Talk Endometrial Alterations That Mimic Cancer & Vice Versa: Problems in Biopsies/Curettages Metaplastic / reactive changes Mucinous change Microglandular hyperplasia-like change Squamous metaplasia
More informationOvarian Clear Cell Carcinoma
Ovarian Clear Cell Carcinoma Rouba Ali-Fehmi, MD Professor of Pathology The Karmanos Cancer Institute, Wayne State University School of Medicine 50 year old woman with chief complaint of shortness of breath
More informationStaging and Treatment Update for Gynecologic Malignancies
Staging and Treatment Update for Gynecologic Malignancies Bunja Rungruang, MD Medical College of Georgia No disclosures 4 th most common new cases of cancer in women 5 th and 6 th leading cancer deaths
More informationCase Presentation. Maha Akkawi, MD, Fatima Obeidat, MD, Tariq Aladily, MD. Department of Pathology Jordan University Hospital Amman, Jordan
Case Presentation Maha Akkawi, MD, Fatima Obeidat, MD, Tariq Aladily, MD Department of Pathology Jordan University Hospital Amman, Jordan The 25th Annual Congress of the ADIAP The 8/11/2013 1 5th International
More informationI have nothing to disclose
A 47 year old female with multiple lung nodules Disclosure of Relevant Financial Relationships Tamar Giorgadze, MD, PhD Professor of Pathology Medical College of Wisconsin Milwaukee, Wisconsin USCAP requires
More information21/07/2017. Hobnail endothelial cells are not the same as epithelioid endothelial cells
UPDATE IN CUTANEOUS VASCULAR S DERMATOPATHOLOGY SESSION BELFAST PATHOLOGY JUNE 21/2017 Dr E Calonje St John s Institute of Dermatology, London, United Kingdom THE FAMILY OF VASCULAR S WITH EPITHELIOID
More informationCase presentation 04/13/2017. Genomic/morphological classification of endometrial carcinoma
Genomic/morphological classification of endometrial carcinoma Robert A. Soslow, MD soslowr@mskcc.org architecture.about.com Case presentation 49 year old woman with vaginal bleeding Underwent endometrial
More information3/27/2017. Disclosure of Relevant Financial Relationships
Ophthalmic Pathology Evening Specialty Conference USCAP 2017 5 th March, 2017 Mukul K. Divatia, MD Assistant Professor Department of Pathology & Genomic Medicine Weill Cornell Medical College Houston Methodist
More informationUpdate in Salivary Gland Pathology. Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016
Update in Salivary Gland Pathology Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016 Objectives Review the different appearances of a selection of salivary gland tumor types Establish
More informationObjectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells
2013 California Society of Pathologists 66 th Annual Meeting San Francisco, CA Atypical Glandular Cells to Early Invasive Adenocarcinoma: Cervical Cytology and Histology Christina S. Kong, MD Associate
More information3/22/2017. Disclosure of Relevant Financial Relationships. Disclosure of Relevant Financial Relationships. Grading G1. Grading. Ki67 index V.
Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to influence or control the content of CME disclose any relevant financial relationship
More informationEndometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors
& 2013 USCAP, Inc. All rights reserved 0893-3952/13 $32.00 95 Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors Kiran Jakate 1, Farshad
More information5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.
Common Differential Diagnoses in Urological Pathology Jonathan I. Epstein Prostate Adenocarcinoma vs. Urothelial Carcinoma 1 2 NKX3.1 NKX3.1 3 4 5 6 Proposed ISUP Recommendations Option to use PSA as a
More informationThe Good Uterine Sarcomas: What Do You Need to Know
The Good Uterine Sarcomas: What Do You Need to Know Anais Malpica, M.D. Departments of Pathology and Gynecologic Oncology The University of Texas M.D. Anderson Cancer Center Matthew Powell, M.D. Division
More informationACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI
USCAP GU Specialty Conference Case 3 March 2016 L. Priya Kunju, M.D. University of Michigan Health System Ann Arbor, MI University of Michigan Health System ACCME/Disclosures The USCAP requires that anyone
More informationENODMETRIAL CARCINOMA: SPECIAL & NOT SO SPECIAL VARIANTS
ENODMETRIAL CARCINOMA: SPECIAL & NOT SO SPECIAL VARIANTS Pacific Northwest Society of Pathologists Vancouver, B.C. September 26, 2015 Teri A. Longacre, M.D. longacre@stanford.edu Stanford University, Stanford,
More informationBOSNIAN-TURKISH CYTOPATHOLOGY SCHOOL June 18-19, 2016 Sarajevo. Case Discussions. 60 year old woman Routine gynecologic control LBC
BOSNIAN-TURKISH CYTOPATHOLOGY SCHOOL June 18-19, 2016 Sarajevo Case Discussions Prof Dr Sıtkı Tuzlalı Tuzlalı Pathology Laboratory 60 year old woman Routine gynecologic control LBC 1 2 Endometrial thickening
More informationUterine epithelioid leiomyosarcoma with c-kit expression and YWHAE gene rearrangement: a case report of a diagnostic pitfall of uterine sarcoma
Kubo et al. Diagnostic Pathology (2017) 12:26 DOI 10.1186/s13000-017-0615-6 CASE REPORT Open Access Uterine epithelioid leiomyosarcoma with c-kit expression and YWHAE gene rearrangement: a case report
More informationA 60-year old Man with Left Jaw Mass. Simon Chiosea, MD University of Pittsburgh medical Center 3/15/2016
ACCME/Disclosures The USCAP requires that anyone in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS which they or their spouse/partner
More informationClassification (1) Classification (3) Classification (2) Spindle cell lesions. Spindle cell lesions of bladder (Mills et al.
Non-epithelial tumours and nonepithelial tumour-like lesions of the bladder Dr Jonathan H Shanks The Christie NHS Foundation Trust, Manchester, UK Classification (1) Myofibroblastic proliferations and
More informationCase Report Clinicopathologic study of endometrial dedifferentiated endometrioid adenocarcinoma: a case report
Int J Clin Exp Pathol 2012;5(1):77-82 www.ijcep.com /ISSN: 1936-2625/IJCEP1111016 Case Report Clinicopathologic study of endometrial dedifferentiated endometrioid adenocarcinoma: a case report Yan Shen
More informationFollicular Lymphoma: the WHO
Follicular Lymphoma: the WHO and the WHERE? Yuri Fedoriw, MD Associate Professor of Pathology and Laboratory Medicine Director of Hematopathology University of North Carolina Chapel Hill, NC Disclosure
More informationPrimary endometrioid stromal sarcomas of the ovary: a clinicopathological study of 14 cases with a review of the literature
/, 2017, Vol. 8, (No. 38), pp: 63345-63352 Primary endometrioid stromal sarcomas of the ovary: a clinicopathological study of 14 cases with a review of the literature Weimin Xie 1, Xiaoning Bi 1, Dongyan
More informationIntraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance
& 2006 USCAP, Inc All rights reserved 0893-3952/06 $30.00 www.modernpathology.org Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance Charles C Guo 1 and
More informationWhat s (new) and Important in Reporting of Uterine Cancers Katherine Vroobel The Royal Marsden
What s (new) and Important in Reporting of Uterine Cancers Katherine Vroobel The Royal Marsden Maastricht Pathology 2018 Wednesday 20 th June Endometrioid adenocarcinoma High grade carcinomas (common)
More information4/12/2018. MUSC Pathology Symposium Kiawah Island April 18, Jesse K. McKenney, MD
MUSC Pathology Symposium Kiawah Island April 18, 2018 Jesse K. McKenney, MD 1 Urothelial Carcinoma with Alternative Differentiation 2 Urothelial Carcinoma with Alternative Differentiation Recognition as
More informationEvening Specialty Conference: Cytopathology
: Cytopathology N. Paul Ohori, M.D. University of Pittsburgh Medical Center Disclosure of Relevant Financial Relationships Disclosure of Relevant Financial Relationships USCAP requires that all planners
More informationBrief History. Identification : Past History : HTN without regular treatment.
Brief History Identification : Name : 陳 x - Admission : 94/10/06 Gender : male Age : 75 y/o Chief Complaint : Urinary difficulty for months. Past History : HTN without regular treatment. Brief History
More informationOvarian carcinoma classification. Robert A. Soslow, MD
Ovarian carcinoma classification Robert A. Soslow, MD soslowr@mskcc.org WHO classification Serous Mucinous Endometrioid Clear cell Transitional Squamous Mixed epithelial Undifferentiated Introduction Rationale
More informationKieran Sultan, PGY4 Penrose St. Francis Hospital
Kieran Sultan, PGY4 Penrose St. Francis Hospital 67 G3, P3 female with no routine medical care and PMH of DM-2. Presented to the ED 10 days after a road trip c/o SOB, intermittent nonproductive cough and
More informationDifferential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital
Differential diagnosis of hematolymphoid tumors composed of medium-sized cells Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Lymphoma classification Lymphoma diagnosis starts with morphologic
More information